Molecular genetic diagnosis for most patients started with a next-generation sequencing (NGS) panel targeting genes associated with albinism—TYR, OCA2, MC1R, MITF, SLC45A2, TYRP1, and GPR143—as the initial clinical diagnosis for all patients was albinism. The gene discussed is OCA2; the disease is albinism.